Header Logo

Connection

Zhibo Yang to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Zhibo Yang has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Zhibo Yang
Connection Strength
0.620
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Towards rapid prediction of drug-resistant cancer cell phenotypes: single cell mass spectrometry combined with machine learning. Chem Commun (Camb). 2019 Jan 10; 55(5):616-619.
    View in: PubMed
    Score: 0.620
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.